1. INTRODUCTION
1.1. Market Overview
1.2. Covid-19 Scenario
1.3. Market Definition
1.4. Market Segmentation
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Driver
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of End-Users
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. ENDOSCOPY SIMULATOR MARKET, BY PROCEDURE
5.1. Introduction
5.2. Upper and Lower Endoscopy
5.3. Bronchoscopy
5.4. Urology
5.5. Others
6. ENDOSCOPY SIMULATOR MARKET, BY END-USER
6.1. Introduction
6.2. Hospital
6.3. Academic Institutes
7. ENDOSCOPY SIMULATOR MARKET, BY GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. United States
7.2.2. Canada
7.2.3. Mexico
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Others
7.4. Europe
7.4.1. Germany
7.4.2. France
7.4.3. UK
7.4.4. Italy
7.4.5. Others
7.5. Middle East and Africa
7.5.1. Saudi Arabia
7.5.2. UAE
7.5.3. Others
7.6. Asia Pacific
7.6.1. China
7.6.2. India
7.6.3. Japan
7.6.4. South Korea
7.6.5. Taiwan
7.6.6. Thailand
7.6.7. Indonesia
7.6.8. Others
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
8.1. Major Players and Strategy Analysis
8.2. Emerging Players and Market Lucrativeness
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Vendor Competitiveness Matrix
9. COMPANY PROFILES
9.1. Karl Storz
9.2. EndoSim
9.3. CAE Healthcare
9.4. Intelligent Haptronic Solutions
9.5. Surgical Science Sweden AB (Simbionix)
9.6. Kyoto Kagaku
9.7. VirtaMed
9.8. Trandomed 3D
9.9. Zhejiang Geyi Medical Instrument Co. Ltd.
9.10. The Chamberlain Group
9.11. AnyMedi Inc.
9.12. Delegge Medical
9.13. Koken Co., Ltd.